Vitreous vascular cell adhesion molecule-1 levels in vitreoretinal pathologies: a prospective analysis of 181 eyes.
OBJECTIVE: To quantify vitreous vascular cell adhesion molecule-1 (VCAM-1) across vitreoretinal pathologies and identify associated factors. DESIGN: Prospective, single-centre, cross-sectional observational study. PARTICIPANTS: A total of 181 eyes of 171 adults undergoing pars plana vitrectomy (PPV). METHODS: Undiluted midvitreous specimens were aspirated before infusion. Eyes were formed into 5 subgroups: advanced proliferative diabetic retinopathy (n = 80), rhegmatogenous retinal detachment (n = 65), vitreomacular interface (VMI) disease (n = 17), retained lens fragments (n = 14), and endophthalmitis (n = 5). VCAM-1 was measured by sandwich enzyme-linked immunosorbent assay. VMI disease was the reference category; no disease-free controls existed. Log-transformed VCAM-1 was analysed by univariable and multivariable regression with Benjamini-Hochberg false discovery rate adjustment. RESULTS: VCAM-1 differed across subgroups (P < 0.001), greatest in endophthalmitis (45 972.61 ± SE 22 130.67 pg/mL; n = 5) and lowest in VMI disease (3669.46 ± 642.42 pg/mL). Chronic kidney disease (P = 0.031) and longer duration of diabetes (unstandardised coefficient B = 411.15 ± 173.65 pg/mL per year; P = 0.020) were associated with greater VCAM-1, although neither group survived false discovery rate adjustment (q = 0.109 and 0.093). Pre-existing glaucoma was independently associated with elevated VCAM-1 (20 126.36 ± 4784.77 vs 9946.15 ± 1147.22 pg/mL; P = 0.003; q = 0.021). CONCLUSIONS: Vitreous VCAM-1 varied across vitreoretinal diagnoses, greatest in endophthalmitis, although on only 5 eyes. Longer duration of diabetes, chronic kidney disease, and pre-existing glaucoma were each associated with greater VCAM-1. These cross-sectional associations are hypothesis-generating and do not establish a mechanistic or causal role.
Authors
- Varun Chaudhary (ORCID: https://orcid.org/0000-0002-9988-4146)
- Tamam El‐Elimat (ORCID: https://orcid.org/0000-0002-9246-4974)
- Seren Al Beiruti
- Rami A. Al-Dwairi (ORCID: https://orcid.org/0000-0002-4187-4527)
- Sahar Khademioore (ORCID: https://orcid.org/0000-0002-3025-0006)
- Abdelwahab Aleshawi
- Maryam Ghadimi
- Ahmed Al Sharie
- Salma Al-Etr
- Aysha Alsarahin
- John Vinitha
- Jinhui Ma
- João Pedro Lima
Institutions
- Jordan University of Science and Technology (JO)
- University of Toronto (CA)
- McMaster University (CA)
Publication Details
- Journal
- PubMed
- Published
- 2026-11-18
- DOI
- https://doi.org/10.1016/j.jcjo.2026.10.005
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00